Press release5 Δεκέμβριος 2022The Commission adopts a Statement of Objections outlining measures to unwind Illumina's blocked acquisition of GRAILPress release1 Δεκέμβριος 2022Commission publishes results of evaluation of State aid rules on services of general economic interest applicable to health and social services and to small aid amountsPress release10 Οκτώβριος 2022Antitrust: Commission sends Statement of Objections to Teva over misuse of the patent system and disparagement of rival multiple sclerosis medicinePress release6 Σεπτέμβριος 2022Mergers: Commission prohibits acquisition of GRAIL by IlluminaPress release19 Ιούλιος 2022Mergers: Commission alleges Illumina and GRAIL breached EU merger rules by early implementation of their acquisitionPress release20 Ιούνιος 2022Antitrust: Commission opens investigation into possible anticompetitive disparagement by Vifor Pharma of iron medicinePress release31 Μάιος 2022The Multilateral Working Group on pharmaceutical mergers launches a public workshopPress release30 Μάρτιος 2022Mergers: Commission partially refers acquisition of a part of McKesson by Phoenix to France's competition authority and clears proposed merger outside FrancePress release29 Οκτώβριος 2021Mergers: Commission adopts interim measures to prevent harm to competition following Illumina's early acquisition of GRAILPress release25 Οκτώβριος 2021Antitrust: Commission carries out unannounced inspections in the animal health sector in BelgiumPress release20 Σεπτέμβριος 2021Mergers: The Commission adopts a Statement of Objections in view of adopting interim measures following Illumina’s early acquisition of GRAIL
Press release5 Δεκέμβριος 2022The Commission adopts a Statement of Objections outlining measures to unwind Illumina's blocked acquisition of GRAIL
Press release1 Δεκέμβριος 2022Commission publishes results of evaluation of State aid rules on services of general economic interest applicable to health and social services and to small aid amounts
Press release10 Οκτώβριος 2022Antitrust: Commission sends Statement of Objections to Teva over misuse of the patent system and disparagement of rival multiple sclerosis medicine
Press release19 Ιούλιος 2022Mergers: Commission alleges Illumina and GRAIL breached EU merger rules by early implementation of their acquisition
Press release20 Ιούνιος 2022Antitrust: Commission opens investigation into possible anticompetitive disparagement by Vifor Pharma of iron medicine
Press release31 Μάιος 2022The Multilateral Working Group on pharmaceutical mergers launches a public workshop
Press release30 Μάρτιος 2022Mergers: Commission partially refers acquisition of a part of McKesson by Phoenix to France's competition authority and clears proposed merger outside France
Press release29 Οκτώβριος 2021Mergers: Commission adopts interim measures to prevent harm to competition following Illumina's early acquisition of GRAIL
Press release25 Οκτώβριος 2021Antitrust: Commission carries out unannounced inspections in the animal health sector in Belgium
Press release20 Σεπτέμβριος 2021Mergers: The Commission adopts a Statement of Objections in view of adopting interim measures following Illumina’s early acquisition of GRAIL
